Meihua Medical Amends Securities Purchase Agreement
Ticker: MHUAF · Form: 6-K · Filed: Jan 3, 2025 · CIK: 1835615
| Field | Detail |
|---|---|
| Company | Meihua International Medical Technologies Co., Ltd. (MHUAF) |
| Form Type | 6-K |
| Filed Date | Jan 3, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $50.5 million, $6,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, securities-purchase-agreement, legal-filing
TL;DR
Meihua Medical (MHMI) amended its SPA from Dec 2023 on Dec 26, 2024. Details to follow.
AI Summary
Meihua International Medical Technologies Co., Ltd. announced on January 3, 2025, that it entered into an amendment to a securities purchase agreement on December 26, 2024. This amendment modifies the original agreement dated December 27, 2023. The company is a Cayman Islands entity and operates in the surgical and medical instruments sector.
Why It Matters
This filing indicates a modification to a key financial agreement, which could impact the company's funding or investor relations.
Risk Assessment
Risk Level: low — The filing is a routine update on a contractual amendment and does not contain immediate negative financial news.
Key Players & Entities
- Meihua International Medical Technologies Co., Ltd. (company) — Registrant
- December 26, 2024 (date) — Date of Amendment
- December 27, 2023 (date) — Original SPA Date
- Cayman Islands (location) — Company Incorporation
FAQ
What specific terms were amended in the securities purchase agreement?
The filing does not specify the exact terms that were amended in the securities purchase agreement, only that an amendment was entered into.
What is the nature of the securities purchase agreement?
The filing does not detail the nature of the securities purchase agreement, only that it was originally dated December 27, 2023, and was amended on December 26, 2024.
When was the amendment to the securities purchase agreement effective?
The amendment to the securities purchase agreement was effective December 26, 2024.
What is the principal executive office address of Meihua International Medical Technologies Co., Ltd.?
The principal executive office is located at 88 Tongda Road, Touqiao Town, Guangling District, Yangzhou, 225000, People's Republic of China.
Does Meihua International Medical Technologies Co., Ltd. file annual reports under Form 20-F or 40-F?
The company indicates it files annual reports under cover of Form 20-F.
Filing Stats: 289 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2025-01-03 08:02:20
Key Financial Figures
- $50.5 million — st Master Fund LP for the sale of up to $50.5 million in convertible notes and warrants. Unde
- $6,000,000 — eed that there would only be the single $6,000,000 closing under the SPA, which occurred o
Filing Documents
- ea0226560-6k_meihua.htm (6-K) — 14KB
- ea022656001ex10-1_meihua.htm (EX-10.1) — 12KB
- 0001213900-25-000512.txt ( ) — 27KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Meihua International Medical Technologies Co., Ltd. Dated: January 3, 2025 By: /s/ Xin Wang Name: Xin Wang Title: Chief Executive Officer (Principal Executive Officer) 2